Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeys

Karen Price, Michael J. Graziano, Helen G. Haggerty et al.|Molecular Cancer Therapeutics|2018

Cited by 11